42 Stocks Moving In Monday's Mid-Day Session

Loading...
Loading...

Gainers

  • Medley Management Inc MDLY shares surged 29.5% to $3.0801 after the company announced a merger agreement with Sierra Income. Medley Capital shareholders will receive 0.67 shares of Sierra stock and $2.96 per share in cash.
  • NovaBay Pharmaceuticals, Inc. NBY rose 28.4% to $1.31 after the company reported better-than-expected Q2 sales results.
  • Pieris Pharmaceuticals, Inc. PIRS rose 17.9% to $5.60. Pieris Pharma said on July 26, European Respiratory Society announced acceptance of late-breaking presentation of company's Phase 1 study of PRS-060.
  • Pluristem Therapeutics Inc. PSTI climbed 14.4% to $5.79.
  • Mylan N.V. MYL rose 12.6% to $20.78 after the company announced a business combination with Pfizer's Upjohn division. The company also reported better-than-expected Q2 results.
  • TCR2 Therapeutics Inc. TCRR shares rose 12.3% to $15.35 after gaining 5.15% on Friday.
  • Research Frontiers Incorporated REFR gained 11.3% to $3.35.
  • Leo Holdings Corp. LHC climbed 10.6% to $10.19.
  • Soligenix, Inc. SNGX shares rose 10.3% to $1.1686 after the company received European patents for Oral BDP in the treatment of acute radiation injury of the gastrointestinal tract.
  • VISTA OIL & GAS/S ADR VIST gained 9.5% to $9.96.
  • CEL-SCI Corporation CVM gained 9.3% to $7.76.
  • Orion Energy Systems, Inc. OESX climbed 9% to $3.1487.
  • Tile Shop Holdings, Inc. TTS gained 7.3% to $2.95.
  • Niu Technologies NIU rose 6.9% to $6.82. Niu Technologies is expected to release Q2 earnings on August 23, 2019.
  • Tower Semiconductor Ltd. TSEM rose 5.3% to $19.29 after the company reported better-than-expected Q2 EPS and sales results.
  • Booz Allen Hamilton Holding Corporation BAH rose 3.4% to $71.51 after the company reported upbeat Q1 earnings results.


Check out these big penny stock gainers and losers

Losers

  • Lexicon Pharmaceuticals, Inc. LXRX shares dipped 73% to $1.54 after the company received a written notice from Sanofi SNY terminating the agreement for the development and commercialization of the company's Diabetes drug candidate Sotagliflozin.
  • iPic Entertainment Inc. IPIC shares fell 43.2% to $1.1525.
  • On Deck Capital Inc ONDK dropped 20.2% to $3.16 after the company reported worse-than-expected Q2 EPS results and narrowed its FY19 sales guidance.
  • Insperity Inc NSP dropped 18.1% to $118.50 after the company issued Q3 EPS guidance below analyst estimates.
  • BP Prudhoe Bay Royalty Trust BPT dipped 13.2% to $7.88.
  • Oil States International, Inc. OIS fell 12.3% to $12.19 following downbeat Q2 results.
  • Avinger, Inc. AVGR tumbled 12.3% to $2.0701.
  • Exact Sciences Corporation EXAS fell 12% to $103.73 after the company announced it will acquire Genomic Health for $72 per share in cash and stock.
  • Neovasc Inc. NVCN dipped 10.7% to $2.43.
  • Fang Holdings Limited SFUN shares dropped 10.6% to $2.2250.
  • GAIN Capital Holdings, Inc. GCAP shares declined 10.2% to $4.22.
  • Alterity Therapeutics Ltd ATHE fell 9.4% to $1.06 after the company announced the completion of its Phase 1 clinical trial for PBT434. The drug was safe and well-tolerated, with adverse event rates comparable to placebo.
  • Harvard Bioscience, Inc. HBIO shares tumbled 8.9% to $2.46.
  • The Joint Corp. JYNT dropped 8.7% to $18.65.
  • Upland Software, Inc. UPLD shares dipped 8.7% to $43.60.
  • Cooper Tire & Rubber Company CTB fell 8.7% to $27.82 after the company reported worse-than-expected Q2 results.
  • Core Laboratories N.V CLB shares declined 8.5% to $48.54.
  • Range Resources Corporation RRC fell 8.2% to $4.7450.
  • Flexible Solutions International Inc. FSI shares fell 8.2% to $2.9739.
  • Neuralstem, Inc. CUR shares tumbled 8% to $2.20 after dropping 35.8% on Friday.
  • Rekor Systems, Inc. REKR shares fell 6.7% to $4.98 after rising 16.85% on Friday.
  • Vermilion Energy Inc VET fell 6.7% to $17.22 after the company reported worse-than-expected Q2 EPS results.
  • Ra Pharmaceuticals, Inc. RARX fell 5.9% to $33.95. Raymond James downgraded Ra Pharmaceuticals from Strong Buy to Market Perform.
  • DISH Network Corp DISH fell 4.4% to $37.77 after Barclays downgraded the stock from Equal-Weight to Underweight and announced a price target of $31 per share.
  • Myriad Genetics, Inc. MYGN dropped 4.3% to $27.70 after Needham downgraded the company from Strong Buy to Hold.
  • Mercury General Corporation MCY dropped 4.3% to $59.49 after the company reported worse-than-expected Q2 EPS and sales results.
Loading...
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralBiotechnologyFinancialsHealth CareMid-Day MoversProperty & Casualty InsuranceTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...